Jeffrey A. Robl

4.5k total citations · 1 hit paper
61 papers, 1.9k citations indexed

About

Jeffrey A. Robl is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jeffrey A. Robl has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Organic Chemistry and 15 papers in Oncology. Recurrent topics in Jeffrey A. Robl's work include Peptidase Inhibition and Analysis (14 papers), Chemical Synthesis and Analysis (14 papers) and Hormonal Regulation and Hypertension (6 papers). Jeffrey A. Robl is often cited by papers focused on Peptidase Inhibition and Analysis (14 papers), Chemical Synthesis and Analysis (14 papers) and Hormonal Regulation and Hypertension (6 papers). Jeffrey A. Robl collaborates with scholars based in United States, Germany and Sweden. Jeffrey A. Robl's co-authors include Richard Sulsky, Rex A. Parker, Ligaya M. Simpkins, Gürol Tuncman, Keita Kono, Cem Z. Görgün, Masato Furuhashi, Liza Makowski, Gen‐ichi Atsumi and Sergio Fazio and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Jeffrey A. Robl

59 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

2007 599 citations Richard Sulsky, Jeffrey A. Robl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey A. Robl United States	23	1.0k	668	242	230	199	61	1.9k
Parimal Misra India	27	1.1k 1.1×	679 1.0×	232 1.0×	182 0.8×	194 1.0×	63	2.0k
Robert J. Ife United Kingdom	23	865 0.9×	417 0.6×	170 0.7×	138 0.6×	91 0.5×	52	1.7k
Kennan Marsh United States	10	848 0.8×	551 0.8×	155 0.6×	183 0.8×	97 0.5×	17	1.5k
Takashi Sohda Japan	20	1.0k 1.0×	789 1.2×	86 0.4×	240 1.0×	176 0.9×	34	1.9k
Robert J. DeVita United States	26	770 0.8×	576 0.9×	85 0.4×	280 1.2×	115 0.6×	71	1.8k
Pascal Grondin France	14	1.4k 1.4×	236 0.4×	190 0.8×	313 1.4×	270 1.4×	16	2.1k
Aaron B. Miller United States	26	1.5k 1.4×	543 0.8×	120 0.5×	148 0.6×	521 2.6×	47	2.8k
Deirdre M. B. Hickey United Kingdom	20	516 0.5×	387 0.6×	164 0.7×	168 0.7×	103 0.5×	40	1.3k
Richard Sulsky United States	12	640 0.6×	203 0.3×	239 1.0×	94 0.4×	135 0.7×	18	1.1k
Raymond F. Kauffman United States	24	1.0k 1.0×	277 0.4×	84 0.3×	512 2.2×	149 0.7×	47	2.2k

Countries citing papers authored by Jeffrey A. Robl

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Robl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Robl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Robl more than expected).

Fields of papers citing papers by Jeffrey A. Robl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Robl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Robl. The network helps show where Jeffrey A. Robl may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Robl

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Robl. A scholar is included among the top collaborators of Jeffrey A. Robl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Robl. Jeffrey A. Robl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Xiang‐Yang, Ying Wang, Karen A. Rossi, et al.. (2014). Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(11). 2539–2545. 18 indexed citations

Yoon, David, Shung Wu, Ramakrishna Seethala, et al.. (2014). Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disorders. Bioorganic & Medicinal Chemistry Letters. 24(21). 5045–5049. 14 indexed citations

Ye, Xiang‐Yang, David Yoon, Akbar Nayeem, et al.. (2013). Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Bioorganic & Medicinal Chemistry Letters. 24(2). 654–660. 14 indexed citations

Fevig, John M., Karen A. Rossi, Keith J. Miller, et al.. (2012). Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(1). 330–335. 10 indexed citations

Ye, Xiang‐Yang, Stephanie Chen, Akbar Nayeem, et al.. (2011). Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Bioorganic & Medicinal Chemistry Letters. 21(22). 6699–6704. 11 indexed citations

Wang, Mengmeng, Qi Wang, Hong Cai, et al.. (2010). Prediction of In Vivo Enantiomeric Compositions by Modeling In Vitro Metabolic Profiles. Journal of Pharmaceutical Sciences. 99(7). 3234–3245. 1 indexed citations

Ahmad, Saleem, Khehyong Ngu, Keith J. Miller, et al.. (2009). Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 20(3). 1128–1133. 13 indexed citations

Li, James J., Haixia Wang, Jun Li, et al.. (2008). Tetrazole based amides as growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(8). 2536–2539. 9 indexed citations

Li, Jun, Stephanie Chen, Brian J. Murphy, et al.. (2008). (d)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(14). 4072–4074. 11 indexed citations

10.

Shi, Yan, Doree Sitkoff, Jing Zhang, et al.. (2007). Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5952–5958. 9 indexed citations

11.

Sulsky, Richard, David R. Magnin, Yanting Huang, et al.. (2006). Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorganic & Medicinal Chemistry Letters. 17(12). 3511–3515. 126 indexed citations

12.

McDonnell, Patricia A., Keith L. Constantine, Valentina Goldfarb, et al.. (2006). NMR Structure of a Potent Small Molecule Inhibitor Bound to Human Keratinocyte Fatty Acid-Binding Protein. Journal of Medicinal Chemistry. 49(16). 5013–5017. 4 indexed citations

13.

Zhao, Guohua, Prakash C. Taunk, David R. Magnin, et al.. (2005). Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(18). 3992–3995. 19 indexed citations

14.

Sulsky, Richard, Jeffrey A. Robl, Scott A. Biller, et al.. (2004). 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP. Bioorganic & Medicinal Chemistry Letters. 14(20). 5067–5070. 26 indexed citations

15.

Robl, Jeffrey A., Ligaya M. Simpkins, Denis E. Ryono, et al.. (1995). ChemInform Abstract: Dual Metalloprotease Inhibitors. Part 3. Utilization of Bicyclic and Monocyclic Diazepinone Based Mercaptoacetyls.. ChemInform. 26(9). 1 indexed citations

16.

Trippodo, N. C., Jeffrey A. Robl, Magdi M. Asaad, et al.. (1995). Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 745–752. 74 indexed citations

17.

Robl, Jeffrey A., Chong‐Qing Sun, Ligaya M. Simpkins, et al.. (1994). Dual metalloprotease inhibitors. III. utilization of bicyclic and monocyclic diazepinone based mercaptoacetyls. Bioorganic & Medicinal Chemistry Letters. 4(16). 2055–2060. 12 indexed citations

18.

Karanewsky, Donald S., Michael C. Badia, Carl P. Ciosek, et al.. (1990). Phosphorus-containing inhibitors of HMG-CoA reductase. I. 4-[(2-Arylethyl)hydroxyphosphinyl]-3-hydroxybutanoic acids: a new class of cell selective inhibitors of cholesterol biosynthesis. Journal of Medicinal Chemistry. 33(11). 2952–2956. 42 indexed citations

19.

Hwu, Jih Ru, et al.. (1987). Instrumentation and Separation Results of Medium Pressure Liquid Chromatography. Journal of Chromatographic Science. 25(11). 501–505. 7 indexed citations

20.

Robl, Jeffrey A. & Jih Ru Hwu. (1985). An efficient method for the generation of N-methyl nitrones. The Journal of Organic Chemistry. 50(26). 5913–5916. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact